Customers are urged not to use these devices due to a risk of tip separation. The FDA first warned the public about this issue in July.

Young M. Lee, MD, a cerebrovascular surgeon with University Medical Center New Orleans, spoke to Cardiovascular Business about his experience using the newly cleared technology.

Sen. Ben Ray Luján, a stroke survivor, introduced the new bill. If passed, it would direct the federal government to study how stroke care is delivered in the United States and fund efforts aimed at improving treatments, data collection and public awareness.

The funding, provided over five years, will go toward developing a robot capable of performing advanced endovascular procedures without direct human input.

The De Ritis ratio could be a new way to anticipate when TAVR patients may face certain short-term risks after treatment.

Gout often goes undertreated, but targeting these patients with urate-lowering therapy can make a big impact on their long-term cardiovascular health.